...
首页> 外文期刊>The journal of pain: official journal of the American Pain Society >Sympathetic-independent bradykinin mechanical hyperalgesia induced by subdiaphragmatic vagotomy in the rat.
【24h】

Sympathetic-independent bradykinin mechanical hyperalgesia induced by subdiaphragmatic vagotomy in the rat.

机译:大鼠dia下迷走神经切断术诱导的非交感神经缓激肽机械痛觉过敏。

获取原文
获取原文并翻译 | 示例

摘要

Bradykinin-induced mechanical hyperalgesia is sympathetically dependent and B(2)-type bradykinin receptor-mediated in the rat; however, a sympathetically independent component of bradykinin hyperalgesia is shown after subdiaphragmatic vagotomy. We evaluated the mechanism of this bradykinin-induced sympathetic-independent mechanical hyperalgesia. The dose-response curve for bradykinin mechanical hyperalgesia in sympathectomized plus vagotomized rats was similar in magnitude to that for sympathetically dependent bradykinin hyperalgesia in normal rats. Although bradykinin mechanical hyperalgesia was mediated by the B(2)-type bradykinin receptors after sympathectomy plus vagotomy, it had a much more rapid latency to onset. This hyperalgesia was significantly attenuated by inhibition of protein kinase A but not protein kinase C, similar to the hyperalgesia produced by prostaglandin E(2), an agent that directly sensitizes primary afferent nociceptors. However, unlike prostaglandin E(2)-induced mechanical hyperalgesia in normal rats, after sympathectomy plus vagotomy, bradykinin-induced hyperalgesia was not attenuated by inhibition of nitric oxide synthesis. Peripheral administration of a [mu ] opioid agonist, [lsqb ]D-Ala(2),N-Me-Phe(4),Gly(5)-ol[rsqb ]-enkephalin, significantly attenuated bradykinin mechanical hyperalgesia after sympathectomy plus vagotomy. These data suggest that after sympathectomy plus subdiaphragmatic vagotomy, bradykinin acts directly on primary afferents to produce mechanical hyperalgesia via a novel protein kinase A-dependent signaling mechanism. [copy ] 2002 by the American Pain Society
机译:缓激肽诱导的机械性痛觉过敏是交感神经依赖性的,并且在大鼠中是B(2)型缓激肽受体介导的;然而,在dia肌下迷走神经切断术后显示了缓激肽痛觉过敏的交感独立成分。我们评估了这种缓激肽诱导的独立于交感神经的机械性痛觉过敏的机制。在交感神经切除和迷走神经切断的大鼠中,缓激肽机械性痛觉过敏的剂量反应曲线的大小与正常大鼠中交感依赖的缓激肽痛觉过敏的剂量反应曲线相似。虽然缓激肽机械性痛觉过敏是由交感神经切除加迷走神经切开术后的B(2)型缓激肽受体介导的,但其起病潜伏期要快得多。这种痛觉过敏可通过抑制蛋白激酶A而不是蛋白激酶C来显着减弱,类似于前列腺素E(2)产生的痛觉过敏,前列腺素E(2)是一种直接敏化初级传入伤害感受器的药物。但是,不同于前列腺素E(2)诱导正常大鼠的机械性痛觉过敏,交感神经切除加迷走神经切断术后,缓激肽诱导的痛觉过敏不会因一氧化氮合成的抑制而减弱。 μ阿片类激动剂[lsqb] D-Ala(2),N-Me-Phe(4),Gly(5)-ol [rsqb]-脑啡肽的外周给药可显着减轻交感神经切除加迷走神经切断术后缓激肽的机械性痛觉过敏。这些数据表明在交感神经切除加plus肌下迷走神经切断后,缓激肽直接作用于初级传入途径,通过新型的蛋白激酶A依赖性信号传导机制产生机械性痛觉过敏。 [复制]美国疼痛学会2002年

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号